IFNα-INDUCED DENDRITIC CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR SENSITIVITY TO DEXAMETHASONE

• Published in: Medit͡s︡inskai͡a︡ immunologii͡a Vol. 19; no. 3; p. 255
• Main Authors: Chernykh, E R, Kurochkina, Yu D, O Yu Leplina, Tikhonova, M A, Tyrinova, T V, Sizikov, A E, Chumasova, O A, Ostanin, A A
• Format: Journal Article
• Language: Russian
• Published: Saint Petersburg Russian Association of Allerologists and Clinical Immuniologists, St. Petersburg Branch 01.01.2017
• Subjects: Age; B7 antigen; CD14 antigen; CD83 antigen; CD86 antigen; Cell activation; Cell proliferation; Dendritic cells; Dexamethasone; Glucocorticoids; Granulocyte-macrophage colony-stimulating factor; Immunosuppressive agents; Inflammation; Interleukin 10; Interleukin 6; Leukocytes (mononuclear); Lymphocytes T; Monocytes; Rheumatoid arthritis; TLR2 protein; Toll-like receptors; α-Interferon
• ISSN: 1563-0625; 2313-741X
• DOI: 10.15789/1563-0625-2017-3-255-266

Dendritic cells (DCs) play an important role in pathogenesis of rheumatoid arthritis (RA) and are considered a novel target for immune therapy. Under inflammatory conditions, local dendritic cells of non-lymphoid organs are thought to be differentiated from monocytes. Moreover, DCs differentiation and activation in RA may be largely controlled by interferon-alpha. The aim of the present study was to investigate phenotypic and functional properties of monocyte-derived DCs generated in the presence of interferonalpha (IFN-DCs) in RA patients, and to specify, whether IFN-DCs are sensitive to a tolerogenic effect of dexamethasone. Fourteen RA patients with moderate-to-high disease activity treated with disease-modifying drugs have been included into the study. Twenty sex- and age-related healthy donors were used as a control. IFN-DCs were generated from monocytes by culturing adherent fraction of mononuclear cells for 5 days with GM-CSF and IFNα in the absence or presence of dexamethasone (10-6 M). IFN-DCs from RA patients were characterized by increased numbers of CD14+CD83- and lower amounts of CD14- CD83+ cells, thus presuming a delayed maturation. Furthermore, IFN-DCs from patients were characterized by higher expression of B7-H1 and TLR2. The phenotypic changes did not significantly influence specific functional activities of DCs, in particular, the capacity of DCs to produce TNFα, IL-10, IL-6, to stimulate proliferation of allogeneic T-cells and to activate T-cells for Th1 and Th2 cytokine production. Generation of patients’ DCs in presence of dexamethasone caused a decrease in CD83 and CD86 expression, reduced TNFα production, and suppressed allostimulatory activity of the DCs. Moreover, dexamethasone inhibited the ability of DC to stimulate Th1 response, along with shifting the balance towards Th2-stimulating activity. The data obtained provide an evidence that IFN-DCs from RA patients remain sensitive to the tolerogenic effects of dexamethasone. Furthermore, the revealed variations in sensitivity of patient’s DCs to dexamethasone-mediated inhibitory effect may be of interest for prediction of therapeutic response to glucocorticoid therapy. Our results also provide an evidence for possible implementation of IFN-DCs as a new cell platform for obtaining tolerogenic DCs.